Date published: 2025-11-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

CEACAM1 CEACAM2 CEACAM3 Inhibitors

Regarding the chemical class of CEACAM1 CEACAM2 CEACAM3 Inhibitors, these are theoretical compounds or agents that are conceived to interact with or modulate the activity of the CEACAM family of proteins. CEACAMs (Carcinoembryonic Antigen-related Cell Adhesion Molecules) are involved in various cellular processes, including cell adhesion, immune response modulation, and intracellular signaling.

The inhibitors for these proteins, in a general sense, can be designed to interfere with the protein-protein interactions, alter the signaling pathways in which these proteins are involved, or modulate the expression levels of these proteins. The inhibitors mentioned above, such as kinase inhibitors (e.g., Wortmannin, LY294002) and pathway-specific inhibitors (e.g., U0126 for MEK1/2), are examples of compounds that may indirectly influence CEACAM proteins by targeting the upstream or downstream components of the signaling pathways they are involved in. For instance, PI3K inhibitors might disrupt signaling cascades that regulate cell proliferation, survival, and metabolism, indirectly affecting CEACAM functions in these processes.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Inhibits PI3K, a kinase involved in many signaling pathways, possibly affecting CEACAM mediated pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Another PI3K inhibitor, potentially alters signaling cascades that interact with CEACAM proteins.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

A p38 MAPK inhibitor, potentially modulating pathways linked to CEACAM function.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, possibly affecting signaling networks involving CEACAM proteins.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor, could alter cellular processes relevant to CEACAM signaling.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$92.00
$223.00
30
(1)

Src family kinase inhibitor, might influence pathways interacting with CEACAMs.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Inhibits Src kinases and Bcr-Abl, potentially impacting CEACAM associated pathways.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$61.00
$83.00
$349.00
155
(1)

NF-κB pathway inhibitor, might affect signaling relevant to CEACAM functions.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MEK inhibitor, potentially alters MAPK/ERK pathway affecting CEACAM signaling.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

EGFR inhibitor, could modulate pathways that intersect with CEACAM related processes.